Legal Representation
Attorney
Christina M. Licursi, Esq.
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 10, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 10, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 2, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 2, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 2, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 30, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 30, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 30, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 9, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 9, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 9, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 18, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 18, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 18, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 25, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 23, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research; providing medical and scientific research information; providing scientific information in the field of cell therapies, biotechnology, and drug development; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields
First Use Anywhere:
Jan 5, 2023
First Use in Commerce:
Jan 5, 2023
Classification
International Classes
042